Alkermes
ALKS
#2605
Rank
NZ$12.13 B
Marketcap
NZ$72.36
Share price
1.25%
Change (1 day)
31.98%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): NZ$0.40 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.56 Billion. In 2025 the company made an earning of NZ$0.54 Billion a decrease over its 2024 earnings that were of NZ$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.40 B-26.08%
2025 NZ$0.54 B-34.87%
2024 NZ$0.83 B-17.97%
2023 NZ$1.01 B-468.52%
2022 -NZ$0.28 Billion449.24%
2021 -NZ$50.05 Million-68.04%
2020 -NZ$0.16 Billion-52.1%
2019 -NZ$0.33 Billion64.49%
2018 -NZ$0.2 Billion-15.04%
2017 -NZ$0.24 Billion-34.2%
2016 -NZ$0.36 Billion-5.34%
2015 -NZ$0.38 Billion35084.97%
2014 -NZ$1.07 Million
2012 NZ$13.22 M-117.81%
2011 -NZ$74.28 Million-12.69%
2010 -NZ$85.07 Million94.3%
2009 -NZ$43.79 Million-117.7%
2008 NZ$0.24 B622.63%
2007 NZ$34.23 M
2004 -NZ$0.14 Billion-14.48%
2003 -NZ$0.16 Billion11.88%
2002 -NZ$0.15 Billion39.65%
2001 -NZ$0.11 Billion5.73%
2000 -NZ$95.83 Million-28.91%
1999 -NZ$0.14 Billion237.28%
1998 -NZ$39.97 Million100.05%
1997 -NZ$19.98 Million-37.93%
1996 -NZ$32.19 Million82.72%
1995 -NZ$17.62 Million-26.79%
1994 -NZ$24.06 Million-72.78%
1993 -NZ$88.39 Million208.07%
1992 -NZ$28.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B 10,948.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.65 B 6,443.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.30 B 2,811.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.75 B 2,918.62%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$21.22 B 4,920.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.53 B 5,942.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-NZ$0.38 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.49 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.85 B 576.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel